Citadel Advisors
FFTY icon

Citadel Advisors’s CapForce IBD 50 ETF FFTY Stock Holding History

Citadel Advisors’s Portfolio FFTY Stock Details FFTY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.36M Buy
40,706
+34,498
+556% +$1.28M ﹤0.01% 6950
2025
Q4 		$216K Buy
+6,208
New +$229K ﹤0.01% 10880
2025
Q3 		– Sell
-32,754
Closed -$1.13M – 13157
2025
Q2 		$1.06M Buy
32,754
+19,403
+145% +$554K ﹤0.01% 6947
2025
Q1 		$360K Sell
13,351
-36,722
-73% -$1.08M ﹤0.01% 9180
2024
Q4 		$1.43M Buy
50,073
+24,464
+96% +$712K ﹤0.01% 6322
2024
Q3 		$689K Sell
25,609
-6,469
-20% -$170K ﹤0.01% 7580
2024
Q2 		$891K Sell
32,078
-13,186
-29% -$359K ﹤0.01% 6827
2024
Q1 		$1.25M Buy
45,264
+2,179
+5% +$57K ﹤0.01% 6473
2023
Q4 		$1.05M Buy
43,085
+4,651
+12% +$106K ﹤0.01% 6575
2023
Q3 		$860K Buy
+38,434
New +$928K ﹤0.01% 6888
2023
Q2 		– Sell
-997
Closed -$23.6K – 14594
2023
Q1 		$23.6K Sell
997
-66,359
-99% -$1.52M ﹤0.01% 12935
2022
Q4 		$1.47M Buy
67,356
+36,811
+121% +$908K ﹤0.01% 6073
2022
Q3 		$747K Sell
30,545
-28,792
-49% -$797K ﹤0.01% 7624
2022
Q2 		$1.59M Buy
59,337
+51,492
+656% +$1.66M ﹤0.01% 6017
2022
Q1 		$307K Sell
7,845
-35,010
-82% -$1.36M ﹤0.01% 10536
2021
Q4 		$1.97M Sell
42,855
-40,873
-49% -$1.95M ﹤0.01% 6281
2021
Q3 		$3.97M Buy
83,728
+68,218
+440% +$3.19M ﹤0.01% 4762
2021
Q2 		$719K Sell
15,510
-20,968
-57% -$949K ﹤0.01% 9195
2021
Q1 		$1.6M Buy
+36,478
New +$1.66M ﹤0.01% 6942
2020
Q3 		– Sell
-26,239
Closed -$903K – 10246
2020
Q2 		$903K Sell
26,239
-7,852
-23% -$244K ﹤0.01% 6015
2020
Q1 		$954K Buy
34,091
+2,143
+7% +$71.4K ﹤0.01% 5413
2019
Q4 		$1.11M Sell
31,948
-22,884
-42% -$774K ﹤0.01% 5406
2019
Q3 		$1.77M Buy
54,832
+34,919
+175% +$1.19M ﹤0.01% 4676
2019
Q2 		$683K Buy
+19,913
New +$671K ﹤0.01% 6314
2019
Q1 		– Sell
-45,228
Closed -$1.25M – 9445
2018
Q4 		$1.25M Buy
45,228
+29,561
+189% +$917K ﹤0.01% 4956
2018
Q3 		$602K Buy
+15,667
New +$576K ﹤0.01% 6396
2017
Q2 		– Sell
-47,810
Closed -$1.23M – 7642
2017
Q1 		$1.23M Buy
47,810
+24,914
+109% +$622K ﹤0.01% 3722
2016
Q4 		$553K Buy
22,896
+4,972
+28% +$116K ﹤0.01% 4744
2016
Q3 		$422K Buy
17,924
+7,706
+75% +$177K ﹤0.01% 5127
2016
Q2 		$219K Sell
10,218
-29,598
-74% -$623K ﹤0.01% 5698
2016
Q1 		$841K Sell
39,816
-41,530
-51% -$839K ﹤0.01% 3688
2015
Q4 		$1.8M Buy
81,346
+29,828
+58% +$684K ﹤0.01% 2844
2015
Q3 		$1.13M Buy
+51,518
New +$1.23M ﹤0.01% 3653

Other funds holding FFTY

CPA
Clear Point Advisors Melville, New York $129M AUM 12.02% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
IWM
IHT Wealth Management Chicago, Illinois $4.3B AUM 21.02% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
CFP
Comprehensive Financial Planning East Petersburg, Pennsylvania $144M AUM 25.61% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
DSCM
Del-Sette Capital Management Schenectady, New York $167M AUM 38.06% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Citadel Advisors's FFTY Position: Q1 2026 in Review

Citadel Advisors increased its CapForce IBD 50 ETF (FFTY) stake by 556% in Q1 2026, buying an estimated $1.28M and bringing the position to 40,706 shares worth $1.36M. The position accounts for ﹤0.01% of the portfolio, ranked #6950.

Citadel Advisors first reported a position in FFTY in Q3 2015 and has held it in 33 quarters since. The position peaked at $3.97M in Q3 2021. 39 funds tracked by Wall St. Rank hold FFTY as of Q1 2026.

  • Citadel Advisors held 40,706 shares of CapForce IBD 50 ETF worth $1.36M as of Q1 2026.
  • Citadel Advisors bought 34,498 CapForce IBD 50 ETF shares in Q1 2026, an estimated $1.28M.
  • CapForce IBD 50 ETF made up ﹤0.01% of Citadel Advisors's portfolio in Q1 2026, its #6950 holding.
  • Citadel Advisors first reported a position in CapForce IBD 50 ETF in Q3 2015 and has held it in 33 quarters since.
  • Citadel Advisors's CapForce IBD 50 ETF position peaked at $3.97M in Q3 2021.
  • 39 funds tracked by Wall St. Rank held CapForce IBD 50 ETF as of Q1 2026.

Based on Citadel Advisors's 13F filing for Q1 2026, filed 15 May 2026.